WHITNEY TATE: Open Payments
NPI 1457834913 · HOUSTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 19 payments from 6 companies in 2025. Trend: 2023 $264 · 2024 $103 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $146 |
| Supernus Pharmaceuticals, Inc. | 4 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Alkermes, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: VRAYLAR, Qelbree, CAPLYTA, ARISTADA, REXULTI, SPRAVATO.
Industry payments across MS — which companies pay providers there.
